Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

June’s top stories: Pfizer’s Phase III study in SCD, Korea begins MERS trial

Pfizer has enrolled the first patient in its Phase III clinical trial (Reset) of rivipansel to treat VOC in sickle cell disease (SCD) patients and South Korea commences trial of experimental plasma treatment for Middle East Respiratory Syndrome (MERS). Drugdevelopment-technology.com wraps up key headlines from June.

Go Top